|
|
|
|
LEADER |
01000caa a22002652c 4500 |
001 |
NLM35074176X |
003 |
DE-627 |
005 |
20250304062053.0 |
007 |
cr uuu---uuuuu |
008 |
231226s2023 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1021/acs.langmuir.2c02408
|2 doi
|
028 |
5 |
2 |
|a pubmed25n1168.xml
|
035 |
|
|
|a (DE-627)NLM35074176X
|
035 |
|
|
|a (NLM)36562662
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a García, Lucia
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Fe3O4-SiO2 Mesoporous Core/Shell Nanoparticles for Magnetic Field-Induced Ibuprofen-Controlled Release
|
264 |
|
1 |
|c 2023
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 11.01.2023
|
500 |
|
|
|a Date Revised 01.02.2023
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Hybrid magnetic nanoparticles made up of an iron oxide, Fe3O4, core and a mesoporous SiO2 shell with high magnetization and a large surface area were proposed as an efficient drug delivery platform. The core/shell structure was synthesized by two seed-mediated growth steps combining solvothermal and sol-gel approaches and using organic molecules as a porous scaffolding template. The system presents a mean particle diameter of 30(5) nm (9 nm magnetic core diameter and 10 nm silica shell thickness) with superparamagnetic behavior, saturation magnetization of 32 emu/g, and a significant AC magnetic-field-induced heating response (SAR = 63 W/gFe3O4, measured at an amplitude of 400 Oe and a frequency of 307 kHz). Using ibuprofen as a model drug, the specific surface area (231 m2/g) of the porous structure exhibits a high molecule loading capacity (10 wt %), and controlled drug release efficiency (67%) can be achieved using the external AC magnetic field for short time periods (5 min), showing faster and higher drug desorption compared to that of similar stimulus-responsive iron oxide-based nanocarriers. In addition, it is demonstrated that the magnetic field-induced drug release shows higher efficiency compared to that of the sustained release at fixed temperatures (47 and 53% for 37 and 42 °C, respectively), considering that the maximum temperature reached during the exposure to the magnetic field is well below (31 °C). Therefore, it can be hypothesized that short periods of exposure to the oscillating field induce much greater heating within the nanoparticles than in the external solution
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
7 |
|a ferric oxide
|2 NLM
|
650 |
|
7 |
|a 1K09F3G675
|2 NLM
|
650 |
|
7 |
|a Drug Carriers
|2 NLM
|
650 |
|
7 |
|a Delayed-Action Preparations
|2 NLM
|
650 |
|
7 |
|a Silicon Dioxide
|2 NLM
|
650 |
|
7 |
|a 7631-86-9
|2 NLM
|
650 |
|
7 |
|a Ibuprofen
|2 NLM
|
650 |
|
7 |
|a WK2XYI10QM
|2 NLM
|
700 |
1 |
|
|a Garaio, Eneko
|e verfasserin
|4 aut
|
700 |
1 |
|
|a López-Ortega, Alberto
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Galarreta-Rodriguez, Itziar
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Cervera-Gabalda, Laura
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Cruz-Quesada, Guillermo
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Cornejo, Alfonso
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Garrido, Julián J
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Gómez-Polo, Cristina
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Pérez-Landazábal, José Ignacio
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Langmuir : the ACS journal of surfaces and colloids
|d 1985
|g 39(2023), 1 vom: 10. Jan., Seite 211-219
|w (DE-627)NLM098181009
|x 1520-5827
|7 nnas
|
773 |
1 |
8 |
|g volume:39
|g year:2023
|g number:1
|g day:10
|g month:01
|g pages:211-219
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1021/acs.langmuir.2c02408
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_22
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_721
|
951 |
|
|
|a AR
|
952 |
|
|
|d 39
|j 2023
|e 1
|b 10
|c 01
|h 211-219
|